CLLKF (BICO Group AB) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CLLKF BICO Group AB CLLKF
61 GF Score
Price $1.58
GF Value $3.68
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is BICO Group AB Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CLLKF
61GF Score
BICO Group AB CLLKF
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BICO Group AB (CLLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued. The current stock price of $1.58 is trading 57.1% below its estimated GF Value™ of $3.68. GuruFocus considers BICO Group AB to be Possible Value Trap.

Key valuation signals for CLLKF:

  • Interest Received:
  • GF Value™: $3.68 vs. price of $1.58 (57.1% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BICO Group AB Business Description

Address Grafiska vagen 2B, Gothenburg, SWE, 412 63
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
61GF Score

Get the complete analysis for CLLKF

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.58
Price
$3.68
GF Value